Apr 22, 2026 08:05AM Inhibrx Inc. (INBX) Cancer Drug Draws Interest From Merck & Co, Others - Reuters

Apr 21, 2026 04:06PM INHIBRX reports interim data on colorectal cancer drug trial

Apr 17, 2026 08:38AM Stifel Reiterates Buy Rating on Inhibrx Biosciences (INBX)

Apr 7, 2026 04:27PM Stifel Starts Inhibrx Biosciences (INBX) at Buy, $150 PT

Mar 19, 2026 04:06PM Inhibrx, Inc. (INBX) Misses Q4 EPS by 48c

Dec 17, 2025 04:58AM Inhibrx's (INBX) 'Data Disclosures Leave us Guessing' - Citizens

Dec 16, 2025 05:00PM INHIBRX Biosciences updates progress on cancer drug trials

Nov 19, 2025 04:19AM Inhibrx Biosciences' (INBX) Ozekibart, INBRX-106 are Lined-up For 2026 - Citizens

Nov 14, 2025 06:14AM Inhibrx, Inc. (INBX) Misses Q3 EPS by 71c

Oct 23, 2025 04:08PM Inhibrx drug meets primary endpoint in rare bone cancer trial

Aug 22, 2025 04:03AM Citizens JMP Reiterates Market Perform Rating on Inhibrx Biosciences (INBX)

Aug 13, 2025 05:58PM Inhibrx, Inc. (INBX) Misses Q2 EPS by 30c

May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025

May 15, 2025 05:24PM Inhibrx, Inc. (INBX) Tops Q1 EPS by 421c

Apr 1, 2025 04:06PM Inhibrx Inc. (INBX) announces CSO change and appoints new President

Mar 18, 2025 04:07AM Citizens JMP Reiterates Market Perform Rating on Inhibrx Biosciences (INBX)

Jan 21, 2025 05:01PM Inhibrx Inc. (INBX) Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

Jan 13, 2025 04:16PM Inhibrx Inc. (INBX) Announces Loan Agreement with Oxford Finance

Nov 15, 2024 07:09AM Inhibrx, Inc. (INBX) Misses Q3 EPS by 136c

Jul 23, 2024 03:03AM JMP Securities Starts Inhibrx Biosciences. (INBX) at Market Perform

Jun 11, 2024 05:15PM Inhibrx Inc. (INBX) Files for 2.45M Share Offering by Selling Stockholders